Get the Stockscreener App
1.145
2.59%
-0.015
Bone Biologics Corp stock is traded at $1.145, with a volume of 91,504.
It is down -2.59% in the last 24 hours and up +2.73% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$1.16
Open:
$1.15
24h Volume:
91,504
Relative Volume:
0.52
Market Cap:
$2.86M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.1579
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
+1.80%
1M Performance:
+2.73%
6M Performance:
-38.59%
1Y Performance:
-61.43%
1-Day Range:
$1.11
$1.17
1-Week Range:
$1.03
$1.29
52-Week Range:
$0.80
$4.74
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.145 | 2.86M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
128.81 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.52 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.20 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.91 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.93 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Bone Biologics Corp Stock (BBLG) Latest News
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Trevi Therapeutics Inc (TRVI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
OMI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
CNQ’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Edison International (EIX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
BBLG’s Stock Journey: What Investors Need to Know About Bone Biologics Corp’s Performance - The InvestChronicle
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 9.8% in January - Defense World
(BBLGW) Technical Pivots with Risk Controls - Stock Traders Daily
Spine Biologics Market Research to 2030: Expansion Fueled - GlobeNewswire
Bone Biologics (OTC:BBLG) Trading Down 6.9% – Here’s Why - Defense World
(BBLGW) Trading Report - Stock Traders Daily
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Orthobiologics Devices And Equipment Market Size, Growth, Trends And Forecast To 2033 - openPR
Orthobiologics Market Overall Study Report 2024-2031 | Zimmer - openPR
Bone Biologics updates ATM offering agreement terms By Investing.com - Investing.com Australia
Bone Biologics updates ATM offering agreement terms - Investing.com
Orthobiologics Devices And Equipment Market In-Depth Analysis of the Research Report 2024-2033: Opportuniti... - WhaTech
Platelet Rich Plasma Market Set for Strong Growth, - GlobeNewswire
Orthobiologics Market Growth in Future Scope 2024-2031 | - openPR
(BBLGW) Proactive Strategies - Stock Traders Daily
Bone Biologics Corp (BBLGW) Quarterly 10-Q Report - Quartzy
Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research - OrthoSpineNews
Orthobiologics Market Is Expected To Reach a Revenue Of USD - GlobeNewswire
Learn to Evaluate (BBLGW) using the Charts - Stock Traders Daily
OFIX INVESTORS: OrthoFix Medical Inc. Stockholders Should Contact Robbins LLP About Joining the Pending OFIX Class Action - The Malaysian Reserve
Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt™ SP - OrthoSpineNews
Bone Growth Products Market Insights Report, 2024-2029: - GlobeNewswire
Long Term Trading Analysis for (BBLGW) - Stock Traders Daily
Orthobiologics Global Market Analysis, Trends, Growth, Research And Forecast 2033 - openPR
Spine Biologics Market Report 2024Spine Biologics Market Trends And Share - openPR
BBLGBone Biologics Corp Latest Stock News & Market Updates - StockTitan
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - StockTitan
Therealreal Inc (REAL) Recovers 161.90% From Low: Sitting In The Catbird Seat? - Stocks Register
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
BBLG’s 2023 Market Dance: Down -67.26% – Time to Invest? - The InvestChronicle
Stock Market Recap: Bone Biologics Corp (BBLG) Concludes at 1.48, a -6.92 Surge/Decline - The Dwinnex
Tetrous®Inc. Announces Issue of an Additional U.S. Patent Related to EnFix® Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures - OrthoSpineNews
TETROUS®, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES - PR Newswire
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation - OrthoSpineNews
Foot Innovate Welcomes New Corporate Partner: Kuros Biosciences - OrthoSpineNews
Ortho Biological Products Market Giants Spending Is Going to Boom - Bacterial Vaccines Market with ...
Bone Biologics announces director resignation - Investing.com India
Bone Biologics announces director resignation By Investing.com - Investing.com South Africa
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Bone Void Fillers Market 2024By Industry Outlook, Future Trends, Growth Analysis And Forecast To 2033 - openPR
Was there any good news for Bone Biologics Corp (BBLG) stock in the last session? - US Post News
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.29%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):